Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-ace tate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET